StockMarketWire.com - Motif Bio said that due to market conditions it has deferred pricing of its proposed public offering of American Depositary Shares and listing of these on the NASDAQ Global Market.

"However, the company intends to continue to engage with investors. The company will provide an update to the market in due course," it said.






Story provided by StockMarketWire.com